Dr. Larian Discusses New Study Surrounding Prevalence of Salivary Gland Tumor Oncocytic Lipoadenoma

Share Article

A new study by the Department of Oral and Maxillofacial Surgery indicates oncocytic lipoadenomaof the parotid gland may not be as rare as initially believed.

Babak Larian
The new research made public surrounding oncocytic lipoadenoma certainly brings a greater insight into the importance of thoroughly examining all benign tumors of the parotid gland.

Babak Larian, MD, FACS in Los Angeles, says that a recent study reviewing the prominence of oncocytic lipoadenoma in sufferers of parotid gland tumors may provide insight into the potentially overlooked relevancy of the disorder. According to the study, oncocytic lipoadenoma, a benign tumor affecting certain patients afflicted with salivary gland disorders, aimed to distinguish whether or not the disease is as rare as it was once believed to be. The study found that oncocytic lipoadenoma is not as atypical as researchers once believed.

“The new research made public surrounding oncocytic lipoadenoma certainly brings a greater insight into the importance of thoroughly examining all benign tumors of the parotid gland,” said Dr. Larian.

In the study, 34 test subjects experiencing oncocytic lipoadenoma of the parotid gland were monitored and examined. Oncocytic lipoadenoma is an extremely rare salivary gland tumor found in a very small percent of the population who salivary gland tumors. The benign tumor is composed of oncocytic epithelial cells and adipose tissue, both in-varied quantities.

The majority of the patients who experience a tumor of the parotid gland undergo a surgery known as a micro-parotidectomy. Because cases ofoncocytic lipoadenoma are presented as a benign tumor, whether or not the mass is removed often depends on how bad the sufferer’s symptoms are. The study found that the duration of symptoms documented between test subjects ranged from fifteen days to eleven years. Dr. Larian is an expert in the performance of minimally invasive parotidectomy, which result in a quicker recovery time and less visible scarring for the patient.

“Nearly all benign tumors of the parotid gland can be removed by minimally invasive parotidectomy or micro-parotidectomy,” said Dr. Larian. "This procedure offers a safe approach that minimizes scarring, and is combined with reconstruction so that the face is symmetric."

Dr. Babak Larian is the Director of the Center for Advanced Parotid Surgery in Los Angeles as well as a highly reputable and experienced board-certified surgeon who specializes in salivary disorders. Dr. Larian is an innovator in minimally invasive surgery techniques. The Center for Advanced Parotid Surgery in Los Angeles is a comprehensive, state of the art medical practice designed to meet the patients' needs at all times while providing the best care and treatment possible.

If you are experiencing trouble brought on by a salivary gland disorder like oncocytic lipoadenoma or would like to learn more about Dr. Larian and his specialty, please call (310) 461-0300 today to schedule your initial consultation. Additional information can also be found on Dr. Larian’swebsite, http://www.parotidmd.com.

Share article on social media or email:

View article via:

Pdf Print